Fairvalue-Calculator Fairvalue-Calculator

Bradsaúde S.A (SAUD3) Fair Value & Analysis

Healthcare · BR · Market cap R$6.9B

PriceR$13.81
Fair ValueR$20.72
Upside+50.0%
Quality91/100
Evidence: High Range R$12.74 – R$26.72

Analysis

Bradsaúde S.A (SAUD3) currently trades at R$13.81, while our model-based Fair Value estimate is R$20.72 — implying the stock looks roughly 50.0% undervalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Bradsaúde S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale and retail trade of products and equipment, sanitizers, drugs, medicines, pharmaceutical inputs, and related items; provision of storage, loading, organization, tidying, custody of goods, technical, and administrative programming services, as well as general management of assets and business. In addition, the company engages in integrating technologies to develop dental solutions; and provide specialized services related to accidents and illnesses, besides actuarial, financial, administrative, and commercial and risk management services. The company was formerly known as Odontoprev S.A. and …

Open the full interactive analysis →

Similar stocks

UnitedHealth Group (UNH) -96% CVS Health Corporation (CVS) -25% Elevance Health, Inc (E1LV34) -80% The Cigna Group (CI) +75% Humana Inc (HUM) -65% Centene Corporation (CNC) +1874%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.